Red Biotechnology Market - Current Developments And Expected Advancements ,Challenges By 2019

Red biotechnology is the application of biotechnology in biopharmaceuticals and pharmaceuticals production. It provides patients with innovative and modern modes of diagnostics and treatments. This biotechnological application involves research and study on cells and tissues, genetic testing, stem cells, gene therapy, orphan drugs, proteomics and pharmacogenetics. The red biotechnology mainly focuses on neurosciences and protein research.

Request Sample pages of premium Research Report: http://bit.ly/2cC2boJ

The global market for red biotechnology is categorized by applications and product types as follows:

• Applications
o Drug discovery
o Drug production
o Gentic testing
o Pharmacogenomics
o Gene therapy
• Product type
o Gene recombinant drugs
o Human vaccines
o Blood products
o Diagnostics reagents
o Others

Currently, North America dominates the global red biotechnology market and is followed by Europe due to increased introduction of new products in the developed markets and number of patents and intellectual property rights granted in the biomedical sector. Emerging economies of Asia-Pacific, Latin America, Middle East and Africa are also expected to emerge as rapidly growing red biotechnology market in the near future due to increasing healthcare expenditure and technological advances.

Some of the major factors driving the global market for red biotechnology include breakthrough outcome of new medical therapies, increase in use of biocatalysis process in the synthesis and production of active pharmaceutical ingredients, advancements in biopharmaceuticals, increasing consumer awareness and government initiatives. However, high capital investment and technical limitations may pose a challenge to the growth of red biotechnology market.

Some of the market players in this industry include Amgen, Inc., Beijing Tiantan Biological Products Co., Ltd., Biogen Idec, Inc., Cephalon, Inc., Chiron Corporation, CSL Limited, Genentech, Inc., Genzyme Corporation, Gilead Sciences, Inc., MedImmune LLC, Serono SA and Shenyang Sunshine Pharmaceutical Co., Ltd.

This research report analyzes this market depending on its market segments, major geographies, and current market trends. Geographies analyzed under this research report include
• North America
• Asia Pacific
• Europe
• Rest of the World

About Us
Transparency Market Research (TMR) is a global market intelligence company providing business information reports and services. The company’s exclusive blend of quantitative forecasting and trend analysis provides forward-looking insight for thousands of decision makers. TMR’s experienced team of analysts, researchers, and consultants use proprietary data sources and various tools and techniques to gather and analyze information.

Contact us:
Transparency Market Research
90 State Street,
Suite 700,
Albany
NY - 12207
United States
Tel: +1-518-618-1030
USA - Canada Toll Free 866-552-3453
Email: sales@transparencymarketresearch.com
Website: http://www.transparencymarketresearch.com/

This release was published on openPR.